Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer.
Saved in:
| Title: | Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer. |
|---|---|
| Authors: | Uppaluri R; Brigham and Women's Hospital, Harvard Medical School, Boston.; Dana-Farber Cancer Institute, Boston., Haddad RI; Brigham and Women's Hospital, Harvard Medical School, Boston.; Dana-Farber Cancer Institute, Boston., Tao Y; Institut Gustave Roussy, Villejuif, France., Le Tourneau C; Institut Curie, Paris., Lee NY; Memorial Sloan Kettering Cancer Center, New York., Westra W; Icahn School of Medicine at Mount Sinai Hospital, New York., Chernock R; Washington University School of Medicine, St. Louis., Tahara M; National Cancer Center Hospital East, Kashiwa, Japan., Harrington KJ; Institute of Cancer Research, Royal Marsden Hospital, London., Klochikhin AL; State Budgetary Institution of Healthcare, Yaroslavl Oncological Hospital, Yaroslavl, Russia., Braña I; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona., Vasconcelos Alves G; Centro Integrado de Pesquisa em Oncologia, Hospital Nossa Senhora de Conceição, Porto Alegre, Brazil., Hughes BGM; Royal Brisbane and Women's Hospital, University of Queensland, Brisbane, Australia., Oliva M; Institut Català d'Oncologia L'Hospitalet, Institut d'Investigació Biomèdica de Bellvitge, Barcelona., Pinto Figueiredo Lima I; Centro Regional Integrado de Oncologia, Fortaleza, Brazil., Ueda T; Hiroshima University Hospital, Hiroshima, Japan., Rutkowski T; Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, Gliwice, Poland., Schroeder U; Department of Otorhinolaryngology, University of Lübeck, Lübeck, Germany., Mauz PS; Department of Otolaryngology, Head and Neck Surgery, University Hospital Tübingen, Tübingen, Germany., Fuereder T; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna., Laban S; Department of Otorhinolaryngology and Head and Neck Surgery, Ulm University Medical Center and Comprehensive Cancer Center Ulm, Ulm, Germany., Oridate N; Yokohama City University School of Medicine, Yokohama, Japan., Popovtzer A; Hadassah Medical Center, Jerusalem., Mach N; Geneva University Hospital, University of Geneva, Geneva., Korobko Y; National Cancer Institute, Kyiv, Ukraine., Costa DA; Hospital CUF Descobertas, Lisbon, Portugal., Hooda-Nehra A; Rutgers Cancer Institute, Newark, NJ.; Division of Hematology-Oncology, Department of Medicine, Rutgers New Jersey Medical School, Newark., Rodriguez CP; Fred Hutchinson Cancer Center, University of Washington, Seattle., Bell RB; Providence Cancer Institute, Earle A. Chiles Research Institute, Portland, OR., Manschot C; Merck, Rahway, NJ., Benjamin K; Merck, Rahway, NJ., Gumuscu B; Merck, Rahway, NJ., Adkins D; Robert Ebert and Greg Stubblefield Head and Neck Tumor Center at Washington University School of Medicine, Alvin J. Siteman Cancer Center, and Barnes-Jewish Hospital, St. Louis. |
| Corporate Authors: | KEYNOTE-689 Investigators |
| Source: | The New England journal of medicine [N Engl J Med] 2025 Jul 03; Vol. 393 (1), pp. 37-50. Date of Electronic Publication: 2025 Jun 18. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study |
| Journal Info: | Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
